Status:

COMPLETED

Cortical Activity During Vojta Stimulation in Healthy Adults

Lead Sponsor:

Josue Fernandez Carnero

Collaborating Sponsors:

Universidad Europea de Madrid

Conditions:

Brain

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The present study is focused on the importance of sensory stimuli at the tactile and proprioceptive level that occur during the activation of the pectoral area, following the treatment protocol of Voj...

Detailed Description

The relationship between intrinsic and extrinsic factors condition the development of the human being. The sensory organs are the main recipients of the information, thanks to them we are able to inte...

Eligibility Criteria

Inclusion

  • Healthy adult population with no history of neurological disease or others that may affect the test.
  • Age between 18 and 50 years.
  • Not having addiction to alcohol or drugs at the time of the study.
  • Not knowing the basics of Vojta Therapy, or knowing the responses of stimuli when applying therapy.
  • Not having the pharmacological treatment that affects the functioning of the Central Nervous System and may interfere with the test results.

Exclusion

  • Those who do not meet the inclusion criteria
  • Not having suffered ms-skeletal alterations in the last 6 months.
  • Known sensory abnormalities.
  • Diagnosis of some neurological pathology or condition that could alter the study such as pain, radiculopathy.
  • Refuse to sign the informed consent.
  • Claustrophobia.
  • Those that can spoil the magnetic resonance image.
  • Be a carrier of some metallic material.
  • Pregnancy or nursing mother.
  • The contraindications of Vojta Therapy.
  • Acute diseases that present with fever and / or inflammation.
  • Vaccination with live germs, according to medical criteria (usually 10 days after vaccination).
  • In case of crystal bone disease, uncontrolled heart disease.

Key Trial Info

Start Date :

January 8 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2020

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04317950

Start Date

January 8 2020

End Date

March 15 2020

Last Update

February 10 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Roberto Cano de la Cuerda

Alcorcón, Madrid, Spain, 28922